These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. [Specific binding of 3H-domperidone--a selective ligand of D2-dopamine receptors--by the human caudate nucleus]. Zlobina GP; Chekalina ND Zh Nevropatol Psikhiatr Im S S Korsakova; 1987; 87(7):1043-5. PubMed ID: 2960110 [TBL] [Abstract][Full Text] [Related]
44. Sex differences in the striatal dopamine D2 receptor binding characteristics in vivo. Pohjalainen T; Rinne JO; Någren K; Syvälahti E; Hietala J Am J Psychiatry; 1998 Jun; 155(6):768-73. PubMed ID: 9619148 [TBL] [Abstract][Full Text] [Related]
45. [The distribution of dopamine D1 and D2 receptors in the brain of rodents and carnivores]. Avgustinovich DF; Nikulina EM Zh Evol Biokhim Fiziol; 1992; 28(1):3-8. PubMed ID: 1387995 [TBL] [Abstract][Full Text] [Related]
46. The role of striatal dopamine D Veselinović T; Vernaleken I; Janouschek H; Cumming P; Paulzen M; Mottaghy FM; Gründer G Psychopharmacology (Berl); 2018 Aug; 235(8):2221-2232. PubMed ID: 29717334 [TBL] [Abstract][Full Text] [Related]
47. Dopamine as the wind of the psychotic fire: new evidence from brain imaging studies. Laruelle M; Abi-Dargham A J Psychopharmacol; 1999 Dec; 13(4):358-71. PubMed ID: 10667612 [TBL] [Abstract][Full Text] [Related]
48. 5-HT2 and D2 receptor occupancy of olanzapine in schizophrenia: a PET investigation. Kapur S; Zipursky RB; Remington G; Jones C; DaSilva J; Wilson AA; Houle S Am J Psychiatry; 1998 Jul; 155(7):921-8. PubMed ID: 9659858 [TBL] [Abstract][Full Text] [Related]
49. Evaluation of Antipsychotic Dose Reduction in Late-Life Schizophrenia: A Prospective Dopamine D2/3 Receptor Occupancy Study. Graff-Guerrero A; Rajji TK; Mulsant BH; Nakajima S; Caravaggio F; Suzuki T; Uchida H; Gerretsen P; Mar W; Pollock BG; Mamo DC JAMA Psychiatry; 2015 Sep; 72(9):927-34. PubMed ID: 26131622 [TBL] [Abstract][Full Text] [Related]
51. Decline of dopamine: effects of age and acute neuroleptic challenge. Lieberman JA; Mailman R Am J Psychiatry; 1998 Mar; 155(3):319-23. PubMed ID: 9501739 [No Abstract] [Full Text] [Related]
52. Dopamine D2 and D3 receptor occupancy in normal humans treated with the antipsychotic drug aripiprazole (OPC 14597): a study using positron emission tomography and [11C]raclopride. Yokoi F; Gründer G; Biziere K; Stephane M; Dogan AS; Dannals RF; Ravert H; Suri A; Bramer S; Wong DF Neuropsychopharmacology; 2002 Aug; 27(2):248-59. PubMed ID: 12093598 [TBL] [Abstract][Full Text] [Related]
53. Brain dopamine receptors in schizophrenia and tardive dyskinesia. Seeman P Psychopharmacology Suppl; 1985; 2():1-8. PubMed ID: 3159008 [TBL] [Abstract][Full Text] [Related]
54. Quantification of neuroreceptors in the living human brain: III. D2-like dopamine receptors: theory, validation, and changes during normal aging. Wong DF; Young D; Wilson PD; Meltzer CC; Gjedde A J Cereb Blood Flow Metab; 1997 Mar; 17(3):316-30. PubMed ID: 9119905 [TBL] [Abstract][Full Text] [Related]